Published in Immunol Lett on March 03, 2008
Exploring the full spectrum of macrophage activation. Nat Rev Immunol (2008) 26.08
IL-12 family cytokines: immunological playmakers. Nat Immunol (2012) 3.12
The cytokines interleukin 27 and interferon-γ promote distinct Treg cell populations required to limit infection-induced pathology. Immunity (2012) 2.52
T-cell exhaustion: characteristics, causes and conversion. Immunology (2010) 2.24
IFN-γ and IL-21 Double Producing T Cells Are Bcl6-Independent and Survive into the Memory Phase in Plasmodium chabaudi Infection. PLoS One (2015) 2.09
CD4+ T cell help and innate-derived IL-27 induce Blimp-1-dependent IL-10 production by antiviral CTLs. Nat Immunol (2011) 1.75
Interleukin-35: odd one out or part of the family? Immunol Rev (2008) 1.60
IL-27 promotes IL-10 production by effector Th1 CD4+ T cells: a critical mechanism for protection from severe immunopathology during malaria infection. J Immunol (2011) 1.56
New directions in the basic and translational biology of interleukin-27. Trends Immunol (2011) 1.54
Role of interleukin 10 transcriptional regulation in inflammation and autoimmune disease. Crit Rev Immunol (2012) 1.49
gp130 at the nexus of inflammation, autoimmunity, and cancer. J Leukoc Biol (2010) 1.48
Neonatal macrophages express elevated levels of interleukin-27 that oppose immune responses. Immunology (2013) 1.46
IL-27 and IL-21 are associated with T cell IL-10 responses in human visceral leishmaniasis. J Immunol (2011) 1.44
Immune response and immunopathology during toxoplasmosis. Semin Immunopathol (2012) 1.38
IL-27 regulates homeostasis of the intestinal CD4+ effector T cell pool and limits intestinal inflammation in a murine model of colitis. J Immunol (2009) 1.21
Molecular interactions within the IL-6/IL-12 cytokine/receptor superfamily. Immunol Res (2011) 1.19
The deubiquitinase A20 mediates feedback inhibition of interleukin-17 receptor signaling. Sci Signal (2013) 1.16
Activation of IL-27 p28 gene transcription by interferon regulatory factor 8 in cooperation with interferon regulatory factor 1. J Biol Chem (2010) 1.11
Transfer of tolerance to collagen type V suppresses T-helper-cell-17 lymphocyte-mediated acute lung transplant rejection. Transplantation (2009) 1.04
Suppression of TNF-α and IL-1 signaling identifies a mechanism of homeostatic regulation of macrophages by IL-27. J Immunol (2010) 1.00
Proinflammatory and regulatory cytokines and chemokines in infants with uncomplicated and severe Plasmodium falciparum malaria. Clin Exp Immunol (2011) 0.98
Impaired CD4+ T-cell proliferation and effector function correlates with repressive histone methylation events in a mouse model of severe sepsis. Eur J Immunol (2010) 0.96
Complement protein C1q bound to apoptotic cells suppresses human macrophage and dendritic cell-mediated Th17 and Th1 T cell subset proliferation. J Leukoc Biol (2014) 0.94
Caveolin-1 plays a critical role in host immunity against Klebsiella pneumoniae by regulating STAT5 and Akt activity. Eur J Immunol (2012) 0.92
IL-27 inhibits OSM-mediated TNF-alpha and iNOS gene expression in microglia. Glia (2010) 0.91
Timed action of IL-27 protects from immunopathology while preserving defense in influenza. PLoS Pathog (2014) 0.91
Regulatory T-cell-associated cytokines in systemic lupus erythematosus. J Biomed Biotechnol (2011) 0.90
Interleukin-27 receptor limits atherosclerosis in Ldlr-/- mice. Circ Res (2012) 0.89
Interleukin-27 treated human macrophages induce the expression of novel microRNAs which may mediate anti-viral properties. Biochem Biophys Res Commun (2013) 0.88
IL-6 mediates the susceptibility of glycoprotein 130 hypermorphs to Toxoplasma gondii. J Immunol (2011) 0.84
Spinal cord pathology in chronic experimental Toxoplasma gondii infection. Eur J Microbiol Immunol (Bp) (2014) 0.84
The presence of interleukin-27 during monocyte-derived dendritic cell differentiation promotes improved antigen processing and stimulation of T cells. Immunology (2015) 0.83
Signaling events involved in interleukin 27 (IL-27)-induced proliferation of human naive CD4+ T cells and B cells. J Biol Chem (2011) 0.83
IL-12 and IL-27 regulate the phagolysosomal pathway in mycobacteria-infected human macrophages. Cell Commun Signal (2014) 0.83
IL-27R-mediated regulation of IL-17 controls the development of respiratory syncytial virus-associated pathogenesis. Am J Pathol (2014) 0.83
Increased Blood Levels of Growth Factors, Proinflammatory Cytokines, and Th17 Cytokines in Patients with Newly Diagnosed Type 1 Diabetes. PLoS One (2015) 0.82
IgG4- related disease as a rare cause of tubulointerstitial nephritis. J Clin Immunol (2014) 0.82
Polymorphisms and plasma levels of IL-27: impact on genetic susceptibility and clinical outcome of bladder cancer. BMC Cancer (2015) 0.81
Interleukin 27 and viral hepatitis: smarter than the average cytokine. Hepatology (2009) 0.81
Coordination between TLR9 signaling in macrophages and CD3 signaling in T cells induces robust expression of IL-30. J Immunol (2012) 0.81
IL-10-induced gp130 expression in mouse mast cells permits IL-6 trans-signaling. J Leukoc Biol (2011) 0.81
IL-27 inhibits hyperglycemia and pancreatic islet inflammation induced by streptozotocin in mice. Am J Pathol (2011) 0.81
Transcriptional suppression of IL-27 production by Mycobacterium tuberculosis-activated p38 MAPK via inhibition of AP-1 binding. J Immunol (2011) 0.81
Memory CD4 T cells induce selective expression of IL-27 in CD8+ dendritic cells and regulate homeostatic naive T cell proliferation. J Immunol (2011) 0.80
Rapamycin augments human DC IL-12p70 and IL-27 secretion to promote allogeneic Type 1 polarization modulated by NK cells. Am J Transplant (2013) 0.80
Interleukin-27 suppresses osteoclastogenesis via induction of interferon-γ. Immunology (2012) 0.80
IL-27 alleviates the bleomycin-induced pulmonary fibrosis by regulating the Th17 cell differentiation. BMC Pulm Med (2015) 0.79
Transcriptomic analysis of global changes in cytokine expression in mouse spleens following acute Toxoplasma gondii infection. Parasitol Res (2015) 0.79
Cytokine and chemokine responses to helminth and protozoan parasites and to fungus and mite allergens in neonates, children, adults, and the elderly. Immun Ageing (2013) 0.79
The myeloid receptor PILRβ mediates the balance of inflammatory responses through regulation of IL-27 production. PLoS One (2012) 0.79
IL-17A promotes susceptibility during experimental visceral leishmaniasis caused by Leishmania donovani. FASEB J (2015) 0.78
IL-10 Modulates Th17 Pathogenicity during Autoimmune Diseases. J Clin Cell Immunol (2016) 0.78
The association between single nucleotide polymorphism in interleukin-27 gene and recurrent pregnancy loss in Iranian women. Iran J Reprod Med (2015) 0.77
IL-27 Promotes Proliferation of Human Leukemic Cell Lines Through the MAPK/ERK Signaling Pathway and Suppresses Sensitivity to Chemotherapeutic Drugs. J Interferon Cytokine Res (2016) 0.76
Restrained Th17 response and myeloid cell infiltration into the central nervous system by human decidua-derived mesenchymal stem cells during experimental autoimmune encephalomyelitis. Stem Cell Res Ther (2016) 0.76
Role of Calprotectin as a Modulator of the IL27-Mediated Proinflammatory Effect on Endothelial Cells. Mediators Inflamm (2015) 0.76
IL-27 Induced by Select Candida spp. via TLR7/NOD2 Signaling and IFN-β Production Inhibits Fungal Clearance. J Immunol (2016) 0.76
Selective depletion of CD11c(+) CD11b(+) dendritic cells partially abrogates tolerogenic effects of intravenous MOG in murine EAE. Eur J Immunol (2016) 0.75
On the cytokine/chemokine network during Plasmodium vivax malaria: new insights to understand the disease. Malar J (2017) 0.75
Cellular cytokine and chemokine responses to parasite antigens and fungus and mite allergens in children co-infected with helminthes and protozoa parasites. J Inflamm (Lond) (2015) 0.75
Ontogeny and localization of the cells produce IL-2 in healthy animals. Cytokine (2013) 0.75
Immunomodulatory activity of interleukin-27 in human chronic periapical diseases. Am J Transl Res (2017) 0.75
Tolerogenic Plasmacytoid Dendritic Cells Control Paracoccidioides brasiliensis Infection by Inducting Regulatory T Cells in an IDO-Dependent Manner. PLoS Pathog (2016) 0.75
Neutrophil polarization by IL-27 as a therapeutic target for intracerebral hemorrhage. Nat Commun (2017) 0.75
Application of bio-orthogonal proteome labeling to cell transplantation and heterochronic parabiosis. Nat Commun (2017) 0.75
Modulation of CD4(+) and CD8(+) T cell function and cytokine responses in Strongyloides stercoralis infection by IL-27 and IL-37. Infect Immun (2017) 0.75
IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J Exp Med (2005) 28.73
Transforming growth factor-beta induces development of the T(H)17 lineage. Nature (2006) 25.91
Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature (2003) 22.89
Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway. Science (2003) 17.57
IL-21 initiates an alternative pathway to induce proinflammatory T(H)17 cells. Nature (2007) 16.59
Divergent pro- and antiinflammatory roles for IL-23 and IL-12 in joint autoimmune inflammation. J Exp Med (2003) 14.60
IL-23 is essential for T cell-mediated colitis and promotes inflammation via IL-17 and IL-6. J Clin Invest (2006) 11.89
IL-27, a heterodimeric cytokine composed of EBI3 and p28 protein, induces proliferation of naive CD4+ T cells. Immunity (2002) 8.19
Interleukin 27 negatively regulates the development of interleukin 17-producing T helper cells during chronic inflammation of the central nervous system. Nat Immunol (2006) 7.89
The inhibitory cytokine IL-35 contributes to regulatory T-cell function. Nature (2007) 7.82
Interleukin 27 limits autoimmune encephalomyelitis by suppressing the development of interleukin 17-producing T cells. Nat Immunol (2006) 6.82
Requirement of interleukin-17A for systemic anti-Candida albicans host defense in mice. J Infect Dis (2004) 6.54
Divergent roles of IL-23 and IL-12 in host defense against Klebsiella pneumoniae. J Exp Med (2005) 6.37
A dominant function for interleukin 27 in generating interleukin 10-producing anti-inflammatory T cells. Nat Immunol (2007) 6.20
Interleukins 27 and 6 induce STAT3-mediated T cell production of interleukin 10. Nat Immunol (2007) 5.99
The IL-27R (WSX-1) is required to suppress T cell hyperactivity during infection. Immunity (2003) 5.60
Analysis of type 2 immunity in vivo with a bicistronic IL-4 reporter. Immunity (2001) 5.46
TH17 cells contribute to uveitis and scleritis and are expanded by IL-2 and inhibited by IL-27/STAT1. Nat Med (2007) 5.41
The IL-12 family of heterodimeric cytokines: new players in the regulation of T cell responses. Immunity (2003) 5.11
Discovery and biology of IL-23 and IL-27: related but functionally distinct regulators of inflammation. Annu Rev Immunol (2007) 4.90
Suppression of autoimmune inflammation of the central nervous system by interleukin 10 secreted by interleukin 27-stimulated T cells. Nat Immunol (2007) 4.66
IL-23 and the Th17 pathway promote inflammation and impair antifungal immune resistance. Eur J Immunol (2007) 4.54
New IL-12-family members: IL-23 and IL-27, cytokines with divergent functions. Nat Rev Immunol (2005) 4.53
WSX-1 is required for resistance to Trypanosoma cruzi infection by regulation of proinflammatory cytokine production. Immunity (2003) 4.07
WSX-1 and glycoprotein 130 constitute a signal-transducing receptor for IL-27. J Immunol (2004) 3.55
Interleukin-6 biology is coordinated by membrane-bound and soluble receptors: role in inflammation and cancer. J Leukoc Biol (2006) 3.45
Cutting edge: role of IL-27/WSX-1 signaling for induction of T-bet through activation of STAT1 during initial Th1 commitment. J Immunol (2003) 3.07
IL-35 is a novel cytokine with therapeutic effects against collagen-induced arthritis through the expansion of regulatory T cells and suppression of Th17 cells. Eur J Immunol (2007) 2.82
CD4+ T cells mediate abscess formation in intra-abdominal sepsis by an IL-17-dependent mechanism. J Immunol (2003) 2.79
Cutting edge: activation of Toll-like receptor 2 induces a Th2 immune response and promotes experimental asthma. J Immunol (2004) 2.67
Suppressive effect of IL-27 on encephalitogenic Th17 cells and the effector phase of experimental autoimmune encephalomyelitis. J Immunol (2007) 2.53
Development of Th1-type immune responses requires the type I cytokine receptor TCCR. Nature (2000) 2.51
WSX-1 is required for the initiation of Th1 responses and resistance to L. major infection. Immunity (2001) 2.49
IL-6-dependent and -independent pathways in the development of interleukin 17-producing T helper cells. Proc Natl Acad Sci U S A (2007) 2.46
IL-27 regulates IL-12 responsiveness of naive CD4+ T cells through Stat1-dependent and -independent mechanisms. Proc Natl Acad Sci U S A (2003) 2.45
A novel interleukin-12 p40-related protein induced by latent Epstein-Barr virus infection in B lymphocytes. J Virol (1996) 2.34
Expression of interleukin-12-related cytokine transcripts in inflammatory bowel disease: elevated interleukin-23p19 and interleukin-27p28 in Crohn's disease but not in ulcerative colitis. Inflamm Bowel Dis (2005) 2.33
The IL-27 receptor chain WSX-1 differentially regulates antibacterial immunity and survival during experimental tuberculosis. J Immunol (2005) 2.26
The IL-27 receptor (WSX-1) is an inhibitor of innate and adaptive elements of type 2 immunity. J Immunol (2004) 2.09
IL-27 and IFN-alpha signal via Stat1 and Stat3 and induce T-Bet and IL-12Rbeta2 in naive T cells. J Interferon Cytokine Res (2003) 2.08
Role of the TRAF binding site and NF-kappaB activation in Epstein-Barr virus latent membrane protein 1-induced cell gene expression. J Virol (1998) 2.02
Epstein-Barr virus-induced gene 3 and the p35 subunit of interleukin 12 form a novel heterodimeric hematopoietin. Proc Natl Acad Sci U S A (1997) 2.02
c-Rel regulates interleukin 12 p70 expression in CD8(+) dendritic cells by specifically inducing p35 gene transcription. J Exp Med (2001) 1.92
Differential regulation of interleukin (IL)-12 p35 and p40 gene expression and interferon (IFN)-gamma-primed IL-12 production by IFN regulatory factor 1. J Exp Med (2003) 1.91
IL-27 limits IL-2 production during Th1 differentiation. J Immunol (2006) 1.89
IL-27 controls the development of inducible regulatory T cells and Th17 cells via differential effects on STAT1. Eur J Immunol (2007) 1.84
Potent antitumor activity of interleukin-27. Cancer Res (2004) 1.80
Molecular phylogeny within type I cytokines and their cognate receptors. Immunity (2003) 1.79
Protection from lethal septic peritonitis by neutralizing the biological function of interleukin 27. J Exp Med (2006) 1.78
Understanding the pro- and anti-inflammatory properties of IL-27. J Immunol (2004) 1.74
IL-27 signaling compromises control of bacterial growth in mycobacteria-infected mice. J Immunol (2004) 1.66
Synergistic activation of interleukin-12 p35 gene transcription by interferon regulatory factor-1 and interferon consensus sequence-binding protein. J Biol Chem (2004) 1.60
Interleukin-27R (WSX-1/T-cell cytokine receptor) gene-deficient mice display enhanced resistance to leishmania donovani infection but develop severe liver immunopathology. Am J Pathol (2006) 1.57
Respiratory syncytial virus infection in the absence of STAT 1 results in airway dysfunction, airway mucus, and augmented IL-17 levels. J Allergy Clin Immunol (2005) 1.52
Antiangiogenic and antitumor activities of IL-27. J Immunol (2006) 1.50
Commensal Gram-negative bacteria prime human dendritic cells for enhanced IL-23 and IL-27 expression and enhanced Th1 development. Eur J Immunol (2004) 1.50
Interleukin-23 and interleukin-27 exert quite different antitumor and vaccine effects on poorly immunogenic melanoma. Cancer Res (2006) 1.49
Positive and negative regulation of the IL-27 receptor during lymphoid cell activation. J Immunol (2005) 1.48
The biology and therapeutic potential of interleukin 27. J Mol Med (Berl) (2007) 1.47
Regulation of IL-27 p28 gene expression in macrophages through MyD88- and interferon-gamma-mediated pathways. J Exp Med (2007) 1.47
IL-27 mediates complete regression of orthotopic primary and metastatic murine neuroblastoma tumors: role for CD8+ T cells. J Immunol (2004) 1.46
Expression of IL-27 in murine carcinoma cells produces antitumor effects and induces protective immunity in inoculated host animals. Int J Cancer (2005) 1.46
Cloning and characterization of a novel class I cytokine receptor. Biochem Biophys Res Commun (1998) 1.37
EBV-induced gene 3 transcription is induced by TLR signaling in primary dendritic cells via NF-kappa B activation. J Immunol (2005) 1.35
IL-27 suppresses CD28-mediated [correction of medicated] IL-2 production through suppressor of cytokine signaling 3. J Immunol (2006) 1.34
Identification of polymorphisms in human interleukin-27 and their association with asthma in a Korean population. J Hum Genet (2007) 1.30
IL-27 synthesis induced by TLR ligation critically depends on IFN regulatory factor 3. J Immunol (2007) 1.26
Expression of IL-27 in human Th1-associated granulomatous diseases. J Pathol (2004) 1.25
IFN-alpha regulates Toll-like receptor-mediated IL-27 gene expression in human macrophages. J Leukoc Biol (2007) 1.25
IL-27 subunits and its receptor (WSX-1) mRNAs are markedly up-regulated in inflammatory cells in the CNS during experimental autoimmune encephalomyelitis. J Neurol Sci (2005) 1.24
Alternatively activated macrophages express the IL-27 receptor alpha chain WSX-1. Immunobiology (2006) 1.23
IFN-beta modulates the response to TLR stimulation in human DC: involvement of IFN regulatory factor-1 (IRF-1) in IL-27 gene expression. Eur J Immunol (2007) 1.22
Augmentation of antigen-presenting and Th1-promoting functions of dendritic cells by WSX-1(IL-27R) deficiency. J Immunol (2007) 1.21
Exacerbation of experimental allergic asthma by augmented Th2 responses in WSX-1-deficient mice. J Immunol (2005) 1.20
Membranous glomerulonephritis development with Th2-type immune deviations in MRL/lpr mice deficient for IL-27 receptor (WSX-1). J Immunol (2005) 1.18
Differential effects of IL-27 on human B cell subsets. J Immunol (2006) 1.18
IL-12 family members: differential kinetics of their TLR4-mediated induction by Salmonella enteritidis and the impact of IL-10 in bone marrow-derived macrophages. Int Immunol (2005) 1.17
Production of IL-27 and other IL-12 family cytokines by microglia and their subpopulations. Brain Res (2005) 1.16
Cutting edge: early IL-4 production governs the requirement for IL-27-WSX-1 signaling in the development of protective Th1 cytokine responses following Leishmania major infection. J Immunol (2004) 1.16
Hyperproduction of proinflammatory cytokines by WSX-1-deficient NKT cells in concanavalin A-induced hepatitis. J Immunol (2004) 1.11
WSX-1: a key role in induction of chronic intestinal nematode infection. J Immunol (2004) 1.08
Regulated expression of gp130 and IL-6 receptor alpha chain in T cell maturation and activation. Int Immunol (1998) 1.03
IL-12: a promising adjuvant for cancer vaccination. Cancer Immunol Immunother (2003) 0.96
Impaired Th1 responses in mice deficient in Epstein-Barr virus-induced gene 3 and challenged with physiological doses of Leishmania major. Eur J Immunol (2005) 0.95
Biology of recently discovered cytokines: discerning the pro- and anti-inflammatory properties of interleukin-27. Arthritis Res Ther (2004) 0.91
Interferon-beta differentially regulates expression of the IL-12 family members p35, p40, p19 and EBI3 in activated human dendritic cells. J Neuroimmunol (2002) 0.87
Bystander activation of CD8+ T cells contributes to the rapid production of IFN-gamma in response to bacterial pathogens. J Immunol (2001) 2.70
Aluminium hydroxide adjuvant initiates strong antigen-specific Th2 responses in the absence of IL-4- or IL-13-mediated signaling. J Immunol (1999) 2.53
Sequence-dependent DNA structure: tetranucleotide conformational maps. J Mol Biol (2000) 2.13
IL-10 mediates susceptibility to Leishmania donovani infection. Eur J Immunol (2001) 1.99
Interleukin-12 and interleukin-18 synergistically induce murine tumor regression which involves inhibition of angiogenesis. J Clin Invest (1998) 1.93
Sequence-dependent DNA structure: dinucleotide conformational maps. J Mol Biol (2000) 1.86
Regulation of tumor necrosis factor production by adrenaline and beta-adrenergic agonists. J Immunol (1992) 1.83
Definitive identification of a gene that confers resistance against Toxoplasma cyst burden and encephalitis. Immunology (1995) 1.76
Mitogen- and antigen-specific proliferation of T cells in murine toxoplasmosis is inhibited by reactive nitrogen intermediates. Infect Immun (1994) 1.66
Host-pathogen interactions: subversion and utilization of the NF-kappa B pathway during infection. Infect Immun (2002) 1.65
An Epidemic of Diarrhea in a New-Born Nursery Caused by Pseudomonas aeruginosa. Am J Public Health Nations Health (1947) 1.51
Inhibition of interferon gamma induced interleukin 12 production: a potential mechanism for the anti-inflammatory activities of tumor necrosis factor. Proc Natl Acad Sci U S A (1998) 1.50
gp130 at the nexus of inflammation, autoimmunity, and cancer. J Leukoc Biol (2010) 1.48
IL-10 enhances NK cell proliferation, cytotoxicity and production of IFN-gamma when combined with IL-18. Eur J Immunol (1999) 1.45
Role of interleukin-10 in regulation of T-cell-dependent and T-cell-independent mechanisms of resistance to Toxoplasma gondii. Infect Immun (1997) 1.44
IL-1 alpha and TNF-alpha are required for IL-12-induced development of Th1 cells producing high levels of IFN-gamma in BALB/c but not C57BL/6 mice. J Immunol (1998) 1.38
Structure and conformation of helical nucleic acids: analysis program (SCHNAaP). J Mol Biol (1997) 1.36
The CD40/CD40 ligand interaction is required for resistance to toxoplasmic encephalitis. Infect Immun (2000) 1.31
Suppression of NF-kappaB activation by infection with Toxoplasma gondii. J Infect Dis (2002) 1.24
The NF-kappa B family member RelB is required for innate and adaptive immunity to Toxoplasma gondii. J Immunol (1999) 1.22
Interleukin-18 (IL-18) enhances innate IL-12-mediated resistance to Toxoplasma gondii. Infect Immun (2000) 1.21
IL-18 and CD28 use distinct molecular mechanisms to enhance NK cell production of IL-12-induced IFN-gamma. J Immunol (1999) 1.20
A DNA damage and stress inducible G protein-coupled receptor blocks cells in G2/M. Proc Natl Acad Sci U S A (1998) 1.18
The CD28/B7 interaction is not required for resistance to Toxoplasma gondii in the brain but contributes to the development of immunopathology. J Immunol (1999) 1.14
Sequence-dependent DNA structure: the role of the sugar-phosphate backbone. J Mol Biol (1998) 1.14
Roles of gamma interferon and other cytokines in suppression of the spleen cell proliferative response to concanavalin A and toxoplasma antigen during acute toxoplasmosis. Infect Immun (1995) 1.13
Identification of STAT4-dependent and independent mechanisms of resistance to Toxoplasma gondii. J Immunol (2000) 1.13
Advances in the use of genetically engineered parasites to study immunity to Toxoplasma gondii. Parasite Immunol (2008) 1.12
Anti-TGF-beta treatment promotes rapid healing of Leishmania major infection in mice by enhancing in vivo nitric oxide production. J Immunol (1999) 1.08
Identification of a role for NF-kappa B2 in the regulation of apoptosis and in maintenance of T cell-mediated immunity to Toxoplasma gondii. J Immunol (2000) 1.07
Structure and conformation of helical nucleic acids: rebuilding program (SCHNArP). J Mol Biol (1997) 1.06
Immunoregulation during toxoplasmosis. Chem Immunol (1998) 1.06
Role of CD28 in the generation of effector and memory responses required for resistance to Toxoplasma gondii. J Immunol (1999) 1.01
Enhancement of intracellular replication of Toxoplasma gondii by IL-6. Interactions with IFN-gamma and TNF-alpha. J Immunol (1994) 1.01
Temporal differences in the expression of mRNA for IL-10 and IFN-gamma in the brains and spleens of C57BL/10 mice infected with Toxoplasma gondii. Parasite Immunol (1994) 0.99
Preferential activation and expansion of human peripheral blood gamma delta T cells in response to Toxoplasma gondii in vitro and their cytokine production and cytotoxic activity against T. gondii-infected cells. J Clin Invest (1995) 0.99
Negative regulation of Th17 responses. Semin Immunol (2008) 0.99
Targeted disruption of the bradyzoite-specific gene BAG1 does not prevent tissue cyst formation in Toxoplasma gondii. Mol Biochem Parasitol (1998) 0.97
Blockade of costimulation prevents infection-induced immunopathology in interleukin-10-deficient mice. Infect Immun (2000) 0.94
A role for CD44 in the production of IFN-gamma and immunopathology during infection with Toxoplasma gondii. J Immunol (2001) 0.92
Quantitative measurements of edge-to-face aromatic interactions by using chemical double-mutant cycles. Chemistry (2001) 0.91
Intestinal pathology during acute toxoplasmosis is IL-4 dependent and unrelated to parasite burden. Parasite Immunol (2004) 0.91
Quantitative determination of intermolecular interactions with fluorinated aromatic rings. Chemistry (2001) 0.89
IL-10 is not required to prevent immune hyperactivity during memory responses to Toxoplasma gondii. Parasite Immunol (2004) 0.88
A supramolecular system for quantifying aromatic stacking interactions. Chemistry (2001) 0.87
Dichloroacetate improves cardiac efficiency after ischemia independent of changes in mitochondrial proton leak. Am J Physiol Heart Circ Physiol (2001) 0.86
Chemotherapy of Trypanosoma brucei infection of the central nervous system: the use of a rapid chemotherapeutic regimen and the development of post-treatment encephalopathies. Trans R Soc Trop Med Hyg (1993) 0.83
Interleukin-10 does not contribute to the pathogenesis of a virulent strain of Toxoplasma gondii. Parasite Immunol (2001) 0.83
Patients infected with Leishmania donovani chagasi can have antibodies that recognize heat shock and acidic ribosomal proteins of Trypanosoma cruzi. Mol Biochem Parasitol (1991) 0.82
The role of the polyamine inhibitor eflornithine in the neuropathogenesis of experimental murine African trypanosomiasis. Neuropathol Appl Neurobiol (1997) 0.81
Alkylamine sensing using langmuir-blodgett films of n-alkyl-N-phenylamide-substituted zinc porphyrins. J Phys Chem B (2008) 0.79
Presence of delta-sleep-inducing peptide-like material in human milk. J Clin Endocrinol Metab (1984) 0.79
Detection of volatile organic compounds using porphyrin derivatives. J Phys Chem B (2010) 0.79
Sequence-structure relationships in DNA oligomers: a computational approach. J Am Chem Soc (2001) 0.78
Altered endochondral ossification in collagen X mouse models leads to impaired immune responses. Dev Dyn (2008) 0.78
Self-assembly of oligomeric porphyrin rings. Org Lett (2000) 0.77
Immunity to Toxoplasma gondii--into the 21st century. Parasite Immunol (2015) 0.77
Similarity in variable antigen type composition of Trypanosoma brucei rhodesiense populations in different sites within the mouse host. Trans R Soc Trop Med Hyg (1986) 0.77
Passive stretch relationships in human uterine muscle. Am J Obstet Gynecol (1966) 0.76
Treatment with interleukin 12 in combination with atovaquone or clindamycin significantly increases survival of mice with acute toxoplasmosis. Antimicrob Agents Chemother (1997) 0.76
Biodegradable microspheres: polyacryl starch microparticles as a delivery system for the antileishmanial drug, sodium stibogluconate. J Pharm Pharmacol (1987) 0.75
Effects of intra-amniotic injection of hypertonic saline on uterine activity, blood and amniotic fluid volumes, and electrolyte concentrations. Am J Obstet Gynecol (1968) 0.75
The goal of learning--to be enlightened. Presidential address. Am J Obstet Gynecol (1976) 0.75
Intrauterine fetal transfusion for severe Rh disease. Northwest Med (1968) 0.75
Toxoplasma gondii induces changes in intracellular calcium in macrophages. Parasitology (2007) 0.75
Immune deficiencies and parasitic diseases. Parasite Immunol (2006) 0.75
Current status of the first postdoctoral year. Present concepts from American surgical boards: obstetrics and gynecology. Bull Am Coll Surg (1975) 0.75
Dysfunction of the forces of labor. Clin Anesth (1965) 0.75
Methodology and evaluation of undergraduate curriculum in obstetrics and gynecology. Am J Obstet Gynecol (1969) 0.75
Aluminum phthalocyanine-streptavidin: new, sensitive fluorescent tracer for immunoassay. Clin Chem (1991) 0.75
Comparison of spontaneous, oxytocin-stimulated, and hypertonic saline-induced labor by different methods of record analysis. Am J Obstet Gynecol (1970) 0.75
The role of natural killer cells in innate resistance to infection. J Immunol (1997) 0.75
Obstetrical management of the Rh negative patient. S D J Med (1965) 0.75
Continuum of medical education in obstetrics and gynecology. J Med Educ (1980) 0.75
Effect of pudendal, spinal, and peridural block anesthesia on the second stage of labor. Am J Obstet Gynecol (1972) 0.75